Keytruda Market to Hit USD 54.78 Billion by 2032: Amid Patent Cliff Resilience | Maximize Market Research
Pembrolizumab has become a core oncology backbone, driving combination therapies and curative regimens across global cancer treatment markets. ROCKVILLE , MD, UNITED STATES, April 29, 2026 /EINPresswire.com/ -- If Pembrolizumab Were a Country, …